A Phase IIIb, Randomized, Double-Blind, Multi-Center, Placebo- Controlled, Dose-Optimization, Cross-Over, Analog Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention-Deficit/Hyperactivity Disorder
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006848/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to assess the time of onset of Vyvanse compared to
placebo, in the analog classroom as measured by the Swanson, Kotkin, Agler, M. Flynn and
Pelham (SKAMP) deportment scale in children (aged 6-12) diagnosed with
Attention-Deficit/Hyperactivity Disorder (ADHD).
提供机构：
Vivli
创建时间：
2021-04-07
